104
Views
0
CrossRef citations to date
0
Altmetric
Reviews

Semisynthesis of Myristic Acid Derivatives and their Biological Activities: A Critical Insight

, , , , , & show all
Pages 455-472 | Received 19 Apr 2020, Accepted 12 Dec 2020, Published online: 03 Jan 2021
 

Abstract

Naturally occurring chemical substances and their semisynthetic derivatives have shown various biological activities. In this context, Myristic acid, a naturally occurring saturated fatty acid found in nutmeg and has shown diverse biological actions against fungi, viruses, cancerous cells, and parasitic microbes. Several semisynthetic derivatives of myristic acid such as esters, amides, and hydrazones are reported to possess a wide spectrum of biological activities especially inhibition of N-myristoyltransferase (NMT) which is necessary for the biological function of the cellular and viral proteins in the malignant transformation of cancerous cells. The analogs, 2-hydroxymyristoyl-CoA, 2-bromomyristoyl-CoA, 2-fluoromyristoyl-CoA have shown competitive inhibition of NMT at Ki=45, 450, 200 nM, respectively. The 11-oxatetradecanoic acid inhibited >99% of cultured trypanosomes within 24 h. The 3-fluoro-13-oxatetradecanoic acid effective against HIV-1 production (ID50 = 1-5 μM). The 2-bromo tetradecanoic acid had the most potent antifungal activities against Saccharomyces cerevisiae (MIC = 10 μM), Candida albicans (MIC = 39 μM), Cryptococcus neoformans (MIC = 20 μM) and Aspergillus niger (MIC < 42 μM) in RPMI 1640 media, respectively. However, 4-oxa tetradecanoic acid and 9-oxatetradecanoic acid were found to be active against Cryptococcus neoformans (MIC=30 μM)) and moderately effective against Saccharomyces cerevisiae (MIC=50 μM). This review highlights the Nutmeg and its contents, chemistry of myristic, semisynthetic modification of myristic acid, and their biological activities.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.